Drug Delivery Infusion Systems are used to administer medications and fluids to critically ill patients by infusion.
The global Drug Delivery Infusion Systems market was estimated at USD 9 billion in 2017. The market is driven by increased prevalence of chronic diseases such as cancer and diabetes coupled with rising demand for improved patient care. As a result, the market will witness increased usage across different therapeutic indication over the forecast period. However, factors concerning patient safety and improper infusion leading to the severe consequences will hamper the growth of the market.
Market Segmentation
The global Drug Delivery Infusion Systems market report segments the market by product type, by application, by end user and by region. On the basis of product, the market is segmented into volume pumps, enteral pumps, syringe pumps, insulin pumps, ambulatory pumps, implantable pupms. Volumetric pumps was the major contributor towards the market in 2017. Based on what these devices are being used and in which therapeutic area, the market is segmented into diabetes, oncology, analgesia, nutrition, haematology, and paediatrics.
Regionally, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific and RoW. North America accounted for the largest market share in the global Drug Delivery Infusion Systems market in 2017 owing to positive government regulations and reimbursement policies. Asia Pacific region recorded the highest growth rate because of rising healthcare expenditure and increasing patient awareness.
The report also profiles the following companies in the Drug Delivery Infusion Systems market - Acromed AG, B. Braun Melsungen AG, Baxter International, Becton Dickinson and Company, Caesarea Medical Electronics Ltd., Flowonix Medical Inc., Fresenius Kabi, IRADIMED CORPORATION, Medtronic, Terumo Corporation, ICU Medical, Inc. and Insulet Corporation.
Scope of the Report:
By Product Type
- Volumetric pumps
- Syringe Infusion Systems
- Ambulatory Infusion Systems
- Implantable Infusion Systems
- Insulin Infusion pumps
- Enteral Infusion Systems
By Application
- Oncology/Chemotherapy
- Diabetes
- Analgesia
- Nutrition
- Haematology
- Paediatrics
By End User
- Hospital
- Ambulatory Surgical Centre
- Home care setting
By Region
- Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
- Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
- North America (The USA, Canada, Mexico)
- South America (Brazil, Argentina, Rest of South America)
- Rest of the World
Why purchase the report?
- Visualize the composition of the Drug Delivery Infusion Systems market across each indication, in terms of type and treatment options, highlighting the key commercial assets and players.
- Identify commercial opportunities in Drug Delivery Infusion Systems market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of the Drug Delivery Infusion Systems market - level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key Drug Delivery Infusion Systems of all major market players
Target Audience:
- Equipment Suppliers/ Buyers
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Research Methodology
- 1.2 Scope of the Report
Chapter 2 Global Drug Delivery Infusion Systems Market - Trends
- 2.1 Key Trends & Developments
Chapter 3 Global Drug Delivery Infusion Systems Market - Industry Analysis
- 3.1 Market Drivers
- 3.1.1. Increased usage of drug delivery infusion systems across different therapeutic indication
- 3.1.2. Increased prevalence of chronic diseases such as cancer and diabetes
- 3.2 Market Restraints
- 3.2.1. Factors concerning patient safety and improper infusion
- 3.3. Threats and Opportunities
- 3.4. Porter's 5 Forces
Chapter 4 Global Drug Delivery Infusion Systems Market - Market Analysis
- 4.1. Drug Delivery Infusion Systems Market- By Product Type
- 4.1.1 Volumetric pumps
- 4.1.2 Syringe Infusion Systems
- 4.1.3 Ambulatory Infusion Systems
- 4.1.4 Implantable Infusion Systems
- 4.1.5 Insulin Infusion pumps
- 4.1.6 Enteral Infusion Systems
- 4.2 Drug Delivery Infusion Systems Market - By Application
- 4.2.1 Oncology/Chemotherapy
- 4.2.2 Diabetes
- 4.2.3 Analgesia
- 4.2.4 Nutrition
- 4.2.5 Haematology
- 4.2.6 Paediatrics
- 4.3 Drug Delivery Infusion Systems Market - By End User
- 4.3.1 Hospital
- 4.3.2 Ambulatory Surgery Centres
- 4.3.3 Homecare Settings
Chapter 5 Global Drug Delivery Infusion Systems Market - Geographical Analysis
- 5.1. North America
- 5.1.1. The USA
- 5.1.2. Canada
- 5.1.3. Mexico
- 5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. The UK
- 5.2.4. Italy
- 5.2.5. Spain
- 5.2.6. Rest of Europe
- 5.3. Asia Pacific
- 5.3.1. China
- 5.3.2. Japan
- 5.3.3. India
- 5.3.4. Australia
- 5.3.5. Rest of Asia Pacific
- 5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
- 5.4.3. Rest of South America
- 5.5 Rest of the World
Chapter 6 Global Drug Delivery Infusion Systems Market - Competitive Landscape
- 6.1. Market Share Analysis
- 6.2. Mergers and Acquisitions Analysis
- 6.3. New Product Launches
Chapter 7 Global Drug Delivery Infusion Systems Market - Company Profiles
- 7.1. Acromed AG
- 7.2. B. Braun Melsungen AG
- 7.3. Baxter International
- 7.4. Becton Dickinson and Company
- 7.5. Caesarea Medical Electronics Ltd.
- 7.6. Flowonix Medical Inc.
- 7.7. Fresenius Kabi
- 7.8. IRADIMED CORPORATION
- 7.9. Medtronic
- 7.10. Terumo Corporation
- 7.11. ICU Medical, Inc.
- 7.12. Insulet Corporation
Chapter 8 Global Drug Delivery Infusion Systems Market - Appendix
- 8.1 Sources
- 8.2 List of Tables
- 8.3 Expert Panel Validation
- 8.4 Disclaimer
- 8.5 Contact Us